Dose-related effects of calcium to enhance the effects of L-tryptophan on gut hormones and energy intake in obesity
Files
(Published version)
Date
2025
Authors
Anjom-Shoae, J.
Fitzgerald, P.C.E.
Horowitz, M.
Holst, J.J.
Rehfeld, J.F.
Veedfald, S.
Feinle-Bisset, C.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Journal of Clinical Endocrinology and Metabolism (JCEM), 2025; 110(9):e2929-e2938
Statement of Responsibility
Javad Anjom-Shoae, Penelope C E Fitzgerald, Michael Horowitz, Jens J Holst, Jens F Rehfeld, Simon Veedfald, Christine Feinle-Bisset
Conference Name
Abstract
Context: In males of normal weight, intraduodenal administration of calcium enhances the effects of the amino acid L-tryptophan (Trp) to suppress energy intake, associated with greater stimulation of cholecystokinin (CCK), glucagon-like peptide-1 (GLP-1), and peptide tyrosine- tyrosine (PYY) secretion (key mechanisms underlying the regulation of pyloric motility and gastric emptying) but not gastrin or glucose- dependent insulinotropic polypeptide (GIP). Objective: Given the implications for the management of obesity, the current study evaluated the effects of calcium, when administered alone and in combination with Trp, on gut hormone secretion, antropyloroduodenal motility, and energy intake in males with obesity. Methods: Fifteen males with obesity and without type 2 diabetes (mean ±SD; age: 27 ±8 years; body mass index: 30±2 kg/m²; hemoglobin A1c: 5.3 ± 0.2%), received 150-minute intraduodenal infusions of 0, 500, or 1000 mg calcium, each combined with Trp (load: 0.1 kcal/min, known to have submaximal energy-intake suppressant effects) from t = 75-150 minutes, on 3 separate occasions, in a randomized, double-blind, cross- over order. Plasma concentrations of gastrin, CCK, GIP, GLP-1, PYY, and pyloric pressures were measured during the infusions. Immediately postinfusion (t = 150-180 minutes), energy intake at a standardized buffet-style lunch was quantified. Results: Calcium, in a dose of 1000 mg, stimulated GLP-1, PYY, and pyloric pressures alone (all P < .05) and enhanced the effects of Trp to stimulate CCK, GLP-1, and PYY (all P < .05), associated with greater suppression of energy intake (P = .01). Energy intake (R = −0.64; P = .001) was inversely related to the dose of calcium, while plasma concentrations of CCK (R = 0.44; P = .05), GLP-1 (R = 0.60; P = .01), and PYY (R = 0.83; P = .01) were directly related. Conclusion: Intraduodenal calcium enhances the effect of intraduodenal Trp to stimulate CCK, GLP-1, and PYY and suppress energy intake in males with obesity.
School/Discipline
Dissertation Note
Provenance
Description
Advance access publication 9 January 2025.
Access Status
Rights
© The Author(s) 2025. Published by Oxford University Press on behalf of the Endocrine Society. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. See the journal About page for additional terms.